Clinical trial for children, adolescents and young adults with post-concussion symptoms

This study is investigating repetitive Transcranial Magnetic Stimulation (rTMS) as potential treatment for children, adolescents and young adults (11-25 years) with persistent post-concussion symptoms.

Participants will be randomised to receive either 10 rTMS treatment or sham treatment (placebo/dummy) over 2 weeks, with the option to receive a further two weeks of 10 rTMS treatment sessions.

Study assessments include advanced brain imaging and activity measurements such as magnetic resonance imaging (MRI) and electroencephalography (EEG), as well as questionnaires to assess well-being and changes in symptoms.

To read more about this trial and eligibility criteria please click here.